Results from Zafirlukast (ACCOLATE) 9188IL/0125 clinical trial.

Study identifier:9188IL/0125

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Official Title

Randomized, Double-blind, Parallel-group Trial to Compare the Safety and Effectiveness of Zafirlukast (ACCOLATE) With That of Pseudoephedrine and Placebo in Subjects With Seasonal Allergic Rhinitis: A Day-in-the-park Trial (9188IL/0125)

Medical condition

-

Phase

-

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

-

Age

-

Date

Study Start Date: -
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Feb 2022 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria